| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CSTL
Castle Biosciences
|
May 29, 2026 | BUY |
Strong Buy
+96.2% avg upside
9 analysts
|
$35.00
65.65% Upside
|
· |
|
RPID
Rapid Micro Biosystems
|
May 29, 2026 | BUY |
Strong Buy
+411.7% avg upside
6 analysts
|
$5.00
192.39% Upside
|
-16.4% |
|
CYRX
CryoPort
|
May 20, 2026 | BUY |
Strong Buy
-4.3% avg upside
15 analysts
|
$17.00
13.20% Upside
|
· |
|
TECH
Bio-Techne
|
May 07, 2026 | HOLD |
Strong Buy
+38.3% avg upside
21 analysts
|
— | +10.3% |
|
XGN
Exagen
|
Mar 11, 2026 | BUY |
Strong Buy
+159.4% avg upside
10 analysts
|
$10.00
120.21% Upside
|
+17.0% |
|
STVN
Stevanato Group
|
Mar 05, 2026 | BUY |
Strong Buy
+53.7% avg upside
13 analysts
|
$32.00
82.37% Upside
|
-84.7% |
|
TKNO
Alpha Teknova
|
Feb 27, 2026 | HOLD |
Strong Buy
+173.6% avg upside
7 analysts
|
— | +100.8% |
|
LAB
Standard BioTools
|
Feb 25, 2026 | HOLD |
Strong Buy
+645.1% avg upside
8 analysts
|
— | -16.2% |
|
RGEN
Repligen
|
Feb 25, 2026 | BUY |
Strong Buy
+28.4% avg upside
25 analysts
|
$220.00
66.73% Upside
|
-7.4% |
|
LFCR
Lifecore Biomedical
|
Dec 29, 2025 | HOLD |
Strong Buy
+73.8% avg upside
9 analysts
|
— | -33.1% |
|
DHR
Danaher
|
Dec 18, 2025 | BUY |
Strong Buy
+21.9% avg upside
45 analysts
|
$310.00
74.97% Upside
|
-20.5% |
|
TMO
Thermo Fisher
|
Dec 08, 2025 | BUY |
Strong Buy
+26.8% avg upside
38 analysts
|
$750.00
61.37% Upside
|
-18.5% |
|
WST
West Pharmaceutical Services
|
Oct 24, 2025 | BUY |
Strong Buy
+6.5% avg upside
17 analysts
|
$350.00
6.75% Upside
|
+11.0% |
|
DE:SRT3
Sartorius
|
Oct 07, 2025 | BUY |
Buy
+27.9% avg upside
17 analysts
|
$320.00
47.52% Upside
|
· |
|
BLFS
BioLife Solutions
|
Oct 03, 2025 | BUY |
Strong Buy
+12.8% avg upside
17 analysts
|
$33.00
26.64% Upside
|
-9.9% |
|
RVTY
Revvity
|
Sep 16, 2025 | BUY |
Buy
+5.2% avg upside
23 analysts
|
$125.00
25.02% Upside
|
+14.9% |
|
ATR
AptarGroup
|
Sep 10, 2025 | BUY |
Buy
+14.4% avg upside
14 analysts
|
$220.00
82.77% Upside
|
-12.5% |
|
CH:YPSN
Ypsomed Holding AG
|
Sep 04, 2025 | BUY |
Strong Buy
+44.0% avg upside
2 analysts
|
$525.00
49.84% Upside
|
· |
|
A
Agilent
|
Aug 28, 2025 | HOLD |
Strong Buy
+3.8% avg upside
32 analysts
|
— | +0.1% |
|
WAT
Waters
|
Aug 18, 2025 | BUY |
Strong Buy
+3.6% avg upside
30 analysts
|
$460.00
29.49% Upside
|
+23.4% |
|
AVTR
Avantor
|
Jun 03, 2025 | BUY |
Buy
+49.6% avg upside
26 analysts
|
$30.00
213.13% Upside
|
-31.0% |
|
HBIO
Harvard Bioscience
|
Apr 09, 2025 | HOLD |
Strong Buy
+161.2% avg upside
3 analysts
|
$30.00
411.09% Upside
|
+16.7% |
|
DE:GXI
Gerresheimer
|
Mar 31, 2025 | HOLD |
Buy
+143.3% avg upside
14 analysts
|
— | · |
|
MLAB
Mesa Laboratories
|
Feb 05, 2025 | HOLD |
Buy
+48.3% avg upside
5 analysts
|
— | -34.0% |
|
CH:LONN
Lonza Group Ltd
|
Jan 30, 2025 | BUY |
Strong Buy
+26.0% avg upside
19 analysts
|
$635.00
28.09% Upside
|
· |
|
MRVI
Maravai Lifesciences Holdings
|
May 09, 2024 | HOLD |
Strong Buy
+175.0% avg upside
17 analysts
|
— | -79.9% |
|
AZTA
Azenta
|
Nov 14, 2023 | HOLD |
Buy
+101.3% avg upside
13 analysts
|
— | -21.7% |
|
TBIO
Telesis Bio
|
Aug 11, 2023 | HOLD |
Buy
+7199900.0% avg upside
7 analysts
|
— | -4.9% |
|
CRL
Charles River Labs
|
May 05, 2022 | BUY |
Strong Buy
+11.9% avg upside
34 analysts
|
$300.00
62.08% Upside
|
-22.9% |
|
IQV
IQVIA Holdings
|
Apr 28, 2022 | BUY |
Strong Buy
+34.5% avg upside
38 analysts
|
$250.00
48.99% Upside
|
-14.2% |
|
IMDX
Insight Molecular Diagnostics
|
Mar 14, 2022 | HOLD |
Buy
-1.2% avg upside
10 analysts
|
— | · |
|
IDXG
Interpace Diagnostics Group
|
Apr 15, 2020 | BUY |
Strong Buy
+617.5% avg upside
9 analysts
|
— | · |
|
NEO
NeoGenomics
|
Feb 27, 2020 | HOLD |
Strong Buy
+37.2% avg upside
17 analysts
|
$30.00
169.54% Upside
|
+85.3% |
|
TTOO
T2 Biosystems
|
Nov 26, 2019 | HOLD |
Buy
+1421150.0% avg upside
10 analysts
|
$2.00
399899.97% Upside
|
· |
|
CSBR
Champions Oncology
|
Jul 24, 2019 | HOLD |
Strong Buy
+34.6% avg upside
6 analysts
|
— | +31.3% |
|
VCYT
Veracyte
|
Nov 29, 2018 | HOLD |
Strong Buy
-20.7% avg upside
17 analysts
|
— | +136.0% |
|
ILMN
Illumina
|
Oct 23, 2017 | HOLD |
Buy
-10.1% avg upside
30 analysts
|
— | +48.3% |
|
BRKR
Bruker
|
Mar 27, 2017 | HOLD |
Buy
-7.0% avg upside
22 analysts
|
— | +30.1% |
|
CRDF
Cardiff Oncology
|
Mar 11, 2016 | HOLD |
Strong Buy
+732.8% avg upside
18 analysts
|
— | -66.7% |
|
CDNA
CareDx
|
Feb 10, 2016 | BUY |
Buy
+25.1% avg upside
16 analysts
|
— | -50.7% |
|
IEX
IDEX
|
Jul 24, 2014 | HOLD |
Buy
-10.6% avg upside
22 analysts
|
$85.00
62.24% Downside
|
-4.5% |
|
PLUG
Plug Power
|
May 05, 2014 | BUY |
Buy
+231.7% avg upside
45 analysts
|
— | -40.4% |
|
NEOG
Neogen
|
Dec 19, 2013 | HOLD |
Buy
+148.1% avg upside
6 analysts
|
$46.00
394.12% Upside
|
+9.8% |
|
QGEN
Qiagen
|
Aug 15, 2013 | HOLD |
Buy
+14.1% avg upside
23 analysts
|
$24.00
35.10% Downside
|
+14.4% |
|
SFES
Safeguard Scientifics
|
Aug 15, 2013 | HOLD |
Buy
+3786.2% avg upside
2 analysts
|
$18.00
3581.77% Upside
|
· |
|
MTD
Mettler-Toledo
|
Aug 15, 2013 | HOLD |
Buy
+2.7% avg upside
18 analysts
|
$255.00
77.67% Downside
|
+18.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.